Issue Date | Title | Author(s) |
2022-06 | A brief history of brain iron accumulation in Parkinson disease and related disorders. | Foley, PB; Hare, DJ; Double, KL |
2018-01-01 | Accumulation of dysfunctional SOD1 protein in Parkinson’s disease is not associated with mutations in the SOD1 gene | Trist, BG; Fifita, JA; Freckleton, SE; Hare, DJ; Lewis, SJG; Halliday, GM; Blair, IP; Double, KL |
2022-09-14 | Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord. | Trist, BG; Genoud, S; Roudeau, S; Rookyard, A; Abdeen, A; Cottam, V; Hare, DJ; White, M; Altvater, J; Fifita, JA; Hogan, A; Grima, N; Blair, IP; Kysenius, K; Crouch, PJ; Carmona, A; Rufin, Y; Claverol, S; Van Malderen, S; Falkenberg, G; Paterson, DJ; Smith, B; Troakes, C; Vance, C; Shaw, CE; Al-Sarraj, S; Cordwell, S; Halliday, G; Ortega, R; Double, KL |
2017-07-01 | Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson’s disease brain | Trist, BG; Davies, KM; Cottam, V; Genoud, S; Ortega, R; Roudeau, S; Carmona, A; De Silva, K; Wasinger, V; Lewis, SJG; Sachdev, P; Smith, B; Troakes, C; Vance, C; Shaw, C; Al-Sarraj, S; Ball, HJ; Halliday, GM; Hare, DJ; Double, KL |
2015-07-07 | Comparative Study of Metal Quantification in Neurological Tissue Using Laser Ablation-Inductively Coupled Plasma-Mass Spectrometry Imaging and X-ray Fluorescence Microscopy | Davies, KM; Hare, DJ; Bohic, S; James, SA; Billings, JL; Finkelstein, DI; Doble, PA; Double, KL |
2014-04-01 | Copper pathology in vulnerable brain regions in Parkinson's disease | Davies, KM; Bohic, S; Carmona, A; Ortega, R; Cottam, V; Hare, DJ; Finberg, JPM; Reyes, S; Halliday, GM; Mercer, JFB; Double, KL |
2017-01-05 | Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson's disease | Hare, DJ; Cardoso, BR; Raven, EP; Double, KL; Finkelstein, DI; Szymlek-Gay, EA; Biggs, B-A |
2016-04-01 | Iron and dopamine: A toxic couple | Hare, DJ; Double, KL |
2012-11-01 | L-DOPA is incorporated into brain proteins of patients treated for Parkinson's disease, inducing toxicity in human neuroblastoma cells in vitro | Chan, SW; Dunlop, RA; Rowe, A; Double, KL; Rodgers, KJ |
2013-01-01 | Localization of copper and copper transporters in the human brain | Davies, KM; Hare, DJ; Cottam, V; Chen, N; Hilgers, L; Halliday, G; Mercer, JFB; Double, KL |
2020 | Meta-analysis of copper and iron in Parkinson's disease brain and biofluids. | Genoud, S; Senior, AM; Hare, DJ; Double, KL |
2019-12-01 | Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease | Trist, BG; Hare, DJ; Double, KL |
2018-07-19 | A Proposed Mechanism for Neurodegeneration in Movement Disorders Characterized by Metal Dyshomeostasis and Oxidative Stress | Trist, BG; Hare, DJ; Double, KL |
2017-10-01 | Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain | Genoud, S; Roberts, BR; Gunn, AP; Halliday, GM; Lewis, SJG; Ball, HJ; Hare, DJ; Double, KL |
2021-01-01 | Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes Neurotoxic. | Trist, BG; Hilton, JB; Hare, DJ; Crouch, PJ; Double, KL |